Among the 10 breast cancer susceptibility genes, 10.3% (13/126) of patients harbored pathogenic germline variations, whereas one patient was observed to possess pathogenic variations in both RAD50 and BRCA1. This evidence concerns the gene BRCA1 and breast cancer.